Abstract
Context:
Pediatric traumatic spinal cord injury (SCI) is an uncommon presentation in the emergency department. Severe injuries are associated with devastating outcomes and complications, resulting in high costs to both the society and the economic system.
Evidence acquisition:
The data on pediatric traumatic spinal cord injuries has been narratively reviewed.
Results:
Pediatric SCI is a life-threatening emergency leading to serious outcomes and high mortality in children if not managed promptly. Pediatric SCI can impose many challenges to neurosurgeons and caregivers because of the lack of large studies with high evidence level and specific guidelines in terms of diagnosis, initial management and of in-hospital treatment options. Several novel potential treatment options for SCI have been developed and are currently under investigation. However, research studies into this field have been limited by the ethical and methodological challenges.
Conclusion:
Future research is needed to investigate the safety and efficacy of the recent uprising neurodegenerative techniques in SCI population. Owing to the current limitations, there is a need to develop novel trial methodologies that can overcome the current methodological and ethical limitations.
Keywords: Child, Neurosurgery, Pediatrics, Spinal Cord Injuries, Trauma
Context
Pediatric traumatic spinal cord injury (SCI) is an uncommon presentation in the emergency department. The specific anatomic features of the pediatric spine and vertebral column are associated with difficulties regarding the diagnostic steps and decision-making (1). Besides that, severe injuries are associated with devastating outcomes and complications, resulting in high costs to both the society and the economic system (2–4). In general, pediatric SCI can impose many challenges to neurosurgeons and caregivers because of the lack of large studies with high evidence level and specific guidelines in terms of diagnosis, initial management and of in-hospital treatment options.
Rehabilitation from SCI is usually incomplete, especially after severe trauma, but new tools are under investigation to improve the outcomes after SCI (5). Some of these tools are being generalized into pediatric populations (6). This review aims to summarize the current practice and evidence regarding pediatric-onset spinal trauma and to give more attention to future therapies using stem cell and bioengineering.
Evidence Acquisition
We searched Medline through PubMed for relevant literature about the pediatric traumatic spinal cord injuries using the following search query “spinal cord injury” AND “children [MESH]”. An expert review author from Zagazig University Hospitals, Zagazig University, Egypt, (AN) was consulted about relevant studies for inclusion. The data on traumatic spinal cord injury have been narratively reviewed.
Results
Epidemiology
Pediatric SCI is a life-threatening emergency leading to serious outcomes and high mortality in children if not managed promptly, in general, the incidence rate of SCI has increased gradually worldwide in the last years and varied from 13.0 per million to 163.0 per million people depending on the expansion of human activities among different regions in the world (7, 8). According to the WHO, there are approximately 250.000 to 500.000 people suffering from SCI annually, and about 78% of new cases are male. Age distribution of cases follows a bimodal fashion with young adults occupying the first peak and adults more than 60 years occupying the second peak (5, 9). There is a variation in the injury prevalence between developed and developing countries (10–12).
In pediatric patients, Traumatic SCI is relatively rare, representing only about 2% to 5% of all spine injuries (13–17). In young people, More than 80% of injuries occur in the cervical spine, while the percentage of cervical regions in adults is only around 30% to 40% (18).
It was also estimated that thoracic and lumbar spine injuries represent 6% to 9% of all pediatric spine trauma (19). After the age of 14, it was found that cervical injuries incidence decreased and resembled adult patient pattern (20).
These epidemiologic properties may be explained by the interference of many factors such as large head size, soft elastic tissue, and supporting structures, and horizontal facet alignment (21, 22). Moreover, mortality rate in cervical spine-injured pediatric patients was reported to range from 16% to 18 %, with higher rate in upper cervical injured patients (23, 24).
Embryology and Anatomy
In embryogenesis of the central nervous system (CNS), Ectoderm is the most important initiating player forming the neural eCTCTctoderm, which gives rise to the neural tube and neural crest, and they subsequently give rise to the brain, spinal cord, and peripheral nerves.
The spinal cord is formed from the neural plate which is constituted by three layers (25): The Ventricular layer that lines the central canal, the Mantle layer that contains neuronal bodies and forms the gray matter and the marginal layer that contains axons, giving rise to the white matter. The spinal cord is the part of the central nervous tissue from which the different spinal nerves arise. It is protected by the vertebral column which has the form of a curved rod containing 33 vertebrae and 23 intervertebral discs. It is divided into five parts: cervical, thoracic, lumbar, sacral, and coccygeal regions. Each vertebra is composed of an anterior and a posterior part. The vertebral body involves the anterior part and is the weight-bearing structure of the vertebral column, and the neural arch (pedicle and posterior elements) consists in the posterior part.
In imaging, understanding the various biomechanical properties and the developmental anatomy of the pediatric cervical spine plays an important role in interpretation. The pediatric cervical spine shows several particularities such as epiphyseal variations, unique vertebral architecture, and incomplete ossification of synchondroses and apophyses. At birth, the neural Arches of the Atlas (C1) are ossified, but the anterior arch is not (only 20%of cases). By the age of 3 to 4, the neural arches fuse posteriorly, and they fuse with the anterior arch by the age of 7 (26, 27).
In terms of the axis development (C2), the fusion of secondary ossification center (which appears at the apex of the dens by 6 to 8 years of age) with the dens fails and results in ossiculum terminal that may be accompanied with atlantoaxial instability in pediatric patients (28–31). Furthermore, the third to seventh cervical vertebrae share similar ossification features with a unique ossification center for the vertebral body and an ossification center for each neural arch, and they have five secondary ossification centers that may remain open till the adulthood (32). The ossification of partially ossified ring apophyses is completed belatedly, and they should not be confused with fractures (30, 33).
A recent review also showed the knowledge of thoracolumbar anatomy and biomechanics is essential as it plays a significant role for the prevention of damage of spine in daily activities that are correlated to low back pain and tissue degeneration (34).
Pathophysiology and Mechanisms of Injury
The pathophysiology of acute SCI occurs in two major stages: immediate mechanical injury resulting in contusions of the spinal cord by permanent or temporary compression followed by secondary phase that may result in dysfunction and neural death after hours to weeks following primary injury due to destructive and biochemical changes in the neuronal and glial cells (35–40). In general, there are three main mechanisms that can engender pediatric SCI.
• Acceleration / Deceleration
Acceleration/deceleration usually result in occipito-atlantal and atlantoaxial injuries. These joints are protected against vertical distraction by the strong fibrous tectorial membrane, which is a strong fibrous ligament that fixes the axis with the occiput, and so any rupture in this ligament requires surgical fusion (41). In young children, occipito-atlantal and atlantoaxial dislocation can occur during high-speed collisions, auto versus pedestrian and may be related to airbag injuries (42). And even if there are any partial or absent neurological deficits, the lesions are worsened by distraction through cervical collar placement and traction (43). Sagittal CT images and MRI can be helpful to detect such lesions in pediatric patients as subluxation may be radiographically occult (44). Odontoid injuries can also occur after high-speed collisions or fall in children less than seven years and usually have a fatal outcome (45). They result from avulsion of the dens of the body of the axis, and this type of injury can be typically detected by lateral radiographs and reconstructed CT images and needs prompt immobilization with or without a halo (1).
In pediatric patients, more than eight years, injuries in the sub-axial ligaments that are usually caused motor-vehicle collisions are more common. They can be typically diagnosed with CT and MRI and usually require only conservative management with immobilization (46, 47).
• Rotational Injury
Falls or collisions can give rise to Atlantoaxial rotatory fixation (AARF) leading to occipito-atlanto dislocation regarding the axis and also functional fixation (44).
There are four types of fixations. In Type I, the atlas is rotated on the odontoid with no anterior displacement. Type II, the atlas is rotated on one lateral articular process resulting in minimal anterior displacement. Type II occurs by rotation of the atlas on both lateral articular processes with an anterior displacement more than 5 mm. Finally, type IV is characterized by rotation and posterior displacement of the atlas (48). CT and MRI are used for diagnosis of these for types of injury and type I improves with a soft collar with or without traction, whereas the other three types require surgical stabilization (49).
• Flexion/Extension
Lateral flexion can result in cervical cord neurapraxia, which is a common type of injury is in contact sports. It is also considered as a mild form of SCI without radiographic abnormality (SCIWORA) and may be accompanied by transitory sensory and motor symptoms in one or all extremities, so it usually requires immobilization for two weeks as a sufficient treatment (50, 51).
Imaging
Plain radiographs are considered the tool of choice in screening for pediatric patients with normal neurological examination while decreasing the dose of radiation and subsequently, the risk of malignancy decrease.
The sensitivity of the lateral film is 73% in young children and increases to reach 93% in children more than eight years old (52). Therefore, the lateral view has the capacity of detecting around 80% of injuries (53). The anteroposterior (AP) view can also be used but has a little role as well as the flexion/extension films.
In children younger than nine years, the odontoid view also has a little role as in this age dens fractures can be detected by the lateral film (54). A retrospective study published in 2017 has reported that CT is superior to X-rays in detecting cervical spine injuries (CSI) in both clinically significant and insignificant injuries independent of the age of patient and injury location (55). However, the use of CT is associated with increasing doses of ionizing radiation and the subsequent risk of malignancy. MRI of cervical spine continues to be the best imaging modality for the diagnosis of soft tissue injuries as ligamentous and cord injuries when compared with CT (56–58).
Applications of the Canadian C-Spine rule and nexus low criteria in emergency condition have widely spread, and this may be due to inadequate cervical spine radiography which reinforces the debate about its utility (59). The last meta-analysis done to evaluate the accuracy of Triage tools for detecting CSI in pediatric patients concluded the lack of enough evidence to determine the accuracy of Canadian C-Spine rule or nexus criteria. Only three cohort studies were eligible for analysis, and so additional studies with large sample size are required to determine their accuracy (60).
SCI without radiographic abnormality (SCIWORA)
SCIWORA in children was defined as the presence of objective signs of acute traumatic myopathy in the absence of spinal column injury on plain radiographs and CT scan (61, 62). Children usually develop SCIWORA from falls and pedestrian versus motor vehicle accidents. It is also important to note that most of the patients may have a significant injury in the spinal cord in spite of normal neuroimaging and normal physical examination, and they present with blunt trauma to the spinal cord with the previous history of transient neurologic deficits or presented by transient numbness, paresthesias, and paralysis that has resolved at the time of initial evaluation, Therefore, clinicians must retain a high suspicion for that and a radiographic follow up is recommended for all patients with SCIWORA. In this regard, a case report presented six years old child with delayed clinical presentation, unusual neuroimaging, and a moderately uneventful clinical course that was diagnosed as SCIWORA (63).
However, with the advance of MRI, the diagnosis of SCIWORA becomes less common. It was found that in cases of clinical-radiologic mismatch or SCIWORA, it is highly recommended to do an MRI of the spine (64). MRI also allows subdivision of SCIWORA cases into detectable intramedullary or extramedullary pathology and those without neuroimaging abnormalities (SCIWONA), but yet there is no implicit prognostic value of MRI findings to guide treatment (65, 66).
A meta-analysis in 2015 showed that the extent of initial neurologic status has a significant association with specific MRI patterns and subsequent outcome. It also recommended an MRI for all pediatric patients experiencing SCI without radiographic abnormality (67).
Management
Steps in the management of patients with acute traumatic SCI are divided into pre-hospital and inhospital measurements (68).
• Pre-hospital Management of Pediatric spinal cord injuries
For pediatric patients, the evidence needed to make recommendations is insufficient. Management of the injured pediatrics needs certain skills and may differ from adults’ treatment (69).
▪ Proper immobilization
Immobilization is one of the most important pre-hospital procedures. It helps prevent more spinal cord injuries and neurological deficit. Traditionally, cervical injuries immobilization is done as in adults by placing the patient over a spinal board and applying cervical collar with bags on both sides of the head (70). However, children may be in severe pain, so, application of collar will be dangerous and difficult. The suitable approach for such cases is pragmatic, allowing the child to find his position then providing manual stabilization.
▪ Pediatric respiration and airway
Airway control is more important in pediatrics than adults as the major cause of cardiac arrest in them is due to hypoxia secondary to respiratory failure compared to cardiac troubles in adults (71). For this reason, early management of respiration is recommended, but unfortunately, pre-hospital providers usually have limited experience in managing the airway in pediatrics.
▪ Pediatric metabolism
The pediatric metabolism differs from that of the adults, and O2 consumption is higher due to the increased surface area to size ratio in children. After SCI, hypothermia is frequently seen. It may lead to higher O2 consumption resulting in lactic acidosis and affecting the coagulation system. Avoiding such complications and maintaining euthermia are essential for life-support (69).
▪ Pediatric cardiovascular system
Controlling blood pressure and maintenance of blood volume by the administration of IV fluid are lifesaving steps. The first fluid bolus, as reported in Pediatric Advanced Life Support guidelines, recommended being up to 60 mL/kg of isotonic crystalloid for initial resuscitation (72). The fluid should be warmed to prevent hypothermia. Crystalloids should be administered carefully; excessive fluids may enhance bleeding and coagulopathy.
• Hospital Resuscitation
▪ Initial hospital evaluation
After arrival and while maintaining Advanced Trauma Life Support guidelines and spinal precautions, the patient state should be evaluated by emergency, surgery, and neurointensive departments. After ABC stability, the team proceeds with a rapid neurologic evaluation. Then attention is given to the spinal cord. The patient entire spinal cord is assessed. At this time, the backboard is removed because of problems associated with prolonged use. There are several tools have been developed to provide a rapid and accurate assessment of the severity of SCI (73). The American Spinal Injury Association (ASIA) scoring system and the ASIA Impairment Scale (AIS) are the most valid and the most widely used (74). The ASIA score form aims at assessing the level of injury and its severity. Certain confounding factors may influence the accuracy of the ASIA scale, such as age, level of consciousness, and other injuries (75).
▪ Initial radiographic analysis
After resuscitation of acute SCI patients, further diagnosis and radiographic evaluation of the spine is needed. Patients should be placed on the spinal board and immobilized until the establishment of the radiographic evaluation; then the patient must be taken off the board to prevent ulcers. This evaluation provides essential information and is needed for decision-making regarding the treatment options.
▪ Respiratory management
Respiratory problems are one of the most frequent causes of morbidity and mortality in children with SCI trauma (76). Pediatrics have smaller lungs and higher metabolism than the adults so pediatrics can tolerate apnea for 2–3 minutes then hypoxia occurs, but the adults can tolerate apnea for a longer duration up to 5 minutes before developing of hypoxia (77). Rapid airway management is a key element in managing patients, and it follows the next steps
▪ Positioning
The injured child is positioned at the sniffing position that can be established by a simple extension of the neck, rolling the shoulder, adding headrest, glabella and chin are horizontally aligned. Also, the mouth and oropharynx should be cleared from any debris or secretions.
▪ Ventilation and Breathing
If the spontaneous ventilation by the positioning is not adequate, hence the child needs assistance. Bag valve mask (BVM) can be a successful procedure. It’s a hand device used for manual resuscitation by providing positive pressure, which helps in the breathing. If there is airway obstruction, BMV will be un-useful till re-opening of the airway either by jaw thrust or chin lift.
▪ Laryngoscope Blades
There are two types of blades, straight and curved. Straight blades insertion into the child’s mouth is easier, but the thinness of this blade makes the manipulation of a large tongue difficult. The curved blade is large and bulky so, it retracts the tongue easily and may be useful in certain pediatric populations when the tongue is larger or bulkier than usual.
▪ Endotracheal Intubation
In endotracheal intubation, a flexible plastic tube is placed in the superior airways through the mouth or nose and usually used in respiratory failure. Rapid sequence intubation (RSI) is the use of some steps including sedatives and neuromuscular blocking agents to facilitate successful intubation and decrease risks of aspiration; Some studies concluded that intubation without some steps of RSI has a lower success rate and higher complication in children and adults (78, 79).
▪ Cardiovascular system management
SCI patients can suffer from different degrees of shock. Differentiating between neurogenic shock (NS) from hemorrhagic shock is a crucial step for adapted management. The incidence of NS depends on the severity of the injury (80). It results in hypotension without tachycardia, and patients respond to intravenous fluid and vasoactive support. Pharmacological support, in this case, is based on α agonists to treat hypotension and β agonists for managing bradycardia. Some patients may have persistent bradycardia due to the loss of sympathetic. Impairment of supra-spinal sympathetic reflex may also occur (81, 82). Postural hypotension may persist after hemodynamic instability resolves. These patients are characterized by reduced catecholamine level (83). Spinal cord recovery can improve postural hypotension, and the adaptation of the reninaldosterone system can solve the problem (84). On the other hand, hemorrhagic shock requires primary control of the source of hemorrhage and aggressive fluid administration, including colloid and crystalloid.
SCI and immobilization may increase the risk of venous thromboembolism (VTE) with a higher incidence in adults than in young people. There is no evidence about VTE prophylaxis and the use of mechanical or pharmacological prophylaxis depending on the clinical presentation of each patient (85).
▪ Autonomic nervous system management
SCI patients suffer from autonomic dysfunction due to unopposed afferent nerve stimulation distal to the injury level leading to hypertension and headache (84). Autonomic dysfunction can occur repetitively and may be asymptomatic. Some SCI patients may experience adrenal insufficiency and must be supplied with hydrocortisone.
• Current pharmacological treatments for SCI
Some medications are used in SCI in adult patients, but there is no clear evidence on the use of these drugs in pediatrics so, further trials targeting this population are necessary. A list of the commonly used drugs in the management of SCI is shown in table 1 (86–102).
Table 1:
The list of the commonly used drugs in the management of spinal cord injuries
Riluzole | It is a glutamate receptor agonist that acts by blocking sodium channels. FDA did not approve its use in SCI, but ongoing trials (NCT01597518, NCT00876889, and NCT02859792) are testing its usage in humans. In a pre-clinical trial, Riluzole had promising results in terms of damaged neurons repair (86). |
Ketorolac | It is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenases (COX1 and COX2). Ketorolac can exert a neuroprotective function as it reduces neuronal death at the site of ischemia (87). |
Minocycline | This antibiotic can have a neuroprotective effect by providing some anti-inflammatory properties and by regulating cytokines metabolism in the central nervous system tissue. Three ongoing trials (NCT00559494, NCT01828203, and NCT01813240) test its usage in SCI, and one published trial (NCT00559494) proved its feasibility in SCI. |
Fingolimod (FTY720) | This drug is a sphingosine receptor agonist. A study illustrated its efficacy in SCI model and showed that its use was associated with motor function improvement (88). |
Magnesium | Magnesium is a neuroprotective agent that acts as an antagonist for N-methyl D-aspartate (NMDA) receptor and as a calcium channel blocker (89). A study has reported that Mg improves motor function on spinal cord rodent models (90). |
Methylprednisolone | This corticosteroid has anti-inflammatory and antioxidant properties. Methylprednisolone can increase the blood flow to the spinal cord but has no role in reversing the problem of neuronal death (91). |
Gacyclidine (GK-11) | This molecule has the role of an N-methyl-d-aspartate receptor antagonist. It had a neuroprotective function in rodent models and improved motor and sensory performance in some model studies (92, 93). Further clinical trials are needed to determine its efficacy. |
GM-1 | It is a ganglioside found in the neuronal cell membrane. Some trials showed up an improvement in ASIA motor score after its usage (94, 95). |
Baclofen | It is γ-aminobutyric acid agonist that inhibits both monosynaptic and polysynaptic reflexes at the spinal level. It can decrease excitatory neurotransmitter release from afferent terminal nerves. Intrathecal baclofen can be used for treating SCI associated spasticity (96, 97). |
Dantrolene | It is a peripheral skeletal muscle relaxant used in muscle spasticity that may have neuroprotective effects after SCI (98, 99). |
Botox | It is made from a neurotoxin secreted by Clostridium botulinum bacteria. Botox is safe and effective in reducing neuropathic pain associated with SCI (100). |
Tizanidine | It is an alpha 2-adrenergic agonist usually used for the treatment of muscle spasticity associated with SCI (101). A study found that Tizanidine is effective in improving walking in higher functioning patients (102). |
• Rehabilitation
Rehabilitation after pediatric SCI is becoming a major step in patients’ care. It requires the collaboration of professionals from many disciplines. Its main goal is to decrease the dependency and to improve the quality of life of the patient. Rehabilitation usually includes inpatient measurements such as wheelchair skills and bed motility and outpatient measurements, which are also called post-discharge measurements (103, 104).
The concept of neuroplasticity has improved SCI management in both adult and pediatric populations by encouraging more scientists and clinicians to investigate the different tools of rehabilitation (105). Excessive research generated one of the most important rehabilitation processes, which are Activity-Based Therapy (ABT). Thanks to the NeuroRecovery Network, 7 ABT centers were implemented in the United States (106). The primary rehabilitation tools for pediatric populations are not thought to provide “natural recovery” because stabilizing the patients in the same position and restricting their movements makes them dependent to the different devices and adds to their paralysis (103, 107). The application of ABT resulted had a positive impact on the improvement of adults’ mobility functions after spinal cord injuries. It is based on the activation of the nervous system with many tools such as intense task-specific practice (108). Collaboration between caregivers and scientists in this field contributed to the extension of activity-based therapy into the pediatric population. They showed up that motor training leads to a significant change in the motility abilities and participation in home and community activities — function outcomes. Function outcomes after rehabilitation can be influenced by many factors such as age, sex, the severity of the injury, and socioeconomic factors. As a consequence, many scaling systems have been developed to predict functional outcomes (ICF and FIM) (6, 104, 109, 110). These scores and scales aim to measure the assistance needed for each patient to improve his performance. NRS is an outcome measure designed for ABT. It has a high psychometric level in adults, and its pediatric version is under development (111).
• Surgical treatment
The surgical interventions in adult traumatic spinal injuries in adults are well detailed and standardized by surgical societies. The spine injuries in young patients must be distinguished from those in adults because of anatomical considerations. However, in a cohort of 75 pediatric patients, the surgical methods and modalities did not differ (112). Pediatric spinal injuries are managed conservatively in most cases. They are useful in stable fractures without neurological lesion and even isolated ligamentous injuries (113, 114). Conservative treatment of the cervical spine may include external stabilization with a soft cervical, a semi-rigid collar, or a halo fixation device (44).
Surgical treatment is mainly indicated in unstable injuries, irreducible fractures or dislocations, progressive neurological deficits resulting from compression, progressive deformity, and in patients aged more than eight years (115, 116). Early surgery may be mandatory in unstable lesions (15). But as a general rule, the indication of surgical therapy for pediatric spinal trauma, particularly in small children with injuries of the cervical spine, remains strictly individual (117).
• Stem Cell Therapy
Mesenchymal stem cells are characterized by their rapid division and high differentiation potency. They exceptionally engender immunoreactive responses after their transplantation. However, the mechanism in which stem cell therapy enhances synapse formation has not been determined yet (118). Researchers think that they provide neurotrophic support and some autocrine and paracrine effects by their secretome. For example, these cells can give an anti-inflammatory power by secreting multiple anti-inflammatory cytokines, including neurotrophin 3 factor (NT-3), IL-10, IL-13, and IL-17E. They can also inhibit the release of pro-inflammatory cytokines by the host or increase the level of IL-10 and promote the polarization of macrophages to an anti-inflammatory phenotype. The anti-inflammatory potential of MSCs, added to their neuroprotection effect, help prevent neural degeneration, and promote neurogenesis and remyelination (119–121).
Since the first attempts of stem cell transplantation SCI, scientists and lab investigators multiplied their efforts in this field (118). A variety of cells were used, such as bone marrow and umbilical cord mesenchymal cells (122, 123). Cellular populations obtained from the cord blood or the umbilical cord resulted in neurotrophic properties in SCI animals (124, 125). The intrathecal transplantation is being tested in a multicenter randomized trial (NCT03521336). Furthermore, Amniotic Fetal mesenchymal stem cells and Adipose-derived mesenchymal stem cells showed limited effects in animal models (126–129). To sum up, Stem cell technologies promote neuronal repair processes with minimal side effects. However, financial and ethical issues can form a real burden against their general application (118).
Discussion
• Future directions for treating SCI
Many promising neuroregeneration interventions have been designed to restore the normal functions after brain and spinal injuries (130). The administration of chondroitinase, which is a bacterial enzyme metabolizing CSPGs, with neural precursor cells, can enhance the axonal remyelination process (131, 132). This remyelination potential has been shown to improve sensorimotor functions in rats (133). Furthermore, the use of NOGO receptor antagonists to block the action of myelin protein NOGOA improved axonal regeneration in animals with spine injury (134, 135). Scientists examined its safety and efficacy in SLA patients (136, 137). Transplant hydrogel polymers constitute a modern method of neurodegeneration. Many molecules have been tested in SCI such as collagen, agarose, fibrin, and hyaluronan (138–142). The use of hydrogel polymers showed a promising result, especially when it was combined with the administration of biological molecules such as growth factors and immunomodulatory factors (143, 144). The results can be explained by the fact that the biomechanical properties of hydrogels delivery systems can promote cellular migration in the spinal cord tissue (145). They can also enhance cell differentiation and stop the immune response after SCI (130).
• Limitations of recent research into SCI treatment
Recent research into SCI is a bit limited by several ethical and methodological challenges. The small sample size of the published studies as well as the lack of comparison against a control group, make it difficult to draw informative conclusions to guide the clinical practice. Withholding a beneficial intervention in SCI patients to test a novel regenerative treatment might be challenging from ethical and methodological points of view. Future researchers should solve this problem by suggesting novel trial methodologies that can overcome the current methodological and ethical limitations. Future research is needed to investigate the safety and efficacy of the recent uprising neuroregenerative techniques in SCI population.
Conclusions
The management of pediatric traumatic spinal cord injuries have been challenged by the lack of class-one evidence about the safety and efficacy of the present treatment options. In addition, the uprising neurodegenerative techniques might hold a promise for treating traumatic SCI in children. Owing to the current limitations, there is a need to develop novel trial methodologies that can overcome the current methodological and ethical limitations.
Acknowledgements
Dr. Ahmed Negida would like to thank his research team (MRGE) for the support and encouragement.
Footnotes
Authors’ contribution
All authors participated in drafting and revising the article.
Conflict of interest
None to declare
Funding
None to declare
Reference
- 1.Lemley K, Bauer P. Pediatric spinal cord injury: Recognition of injury and initial resuscitation, in hospital management, and coordination of care. J Pediatr Intensive Care. 2015;4(1):27–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vogel LC, Krajci KA, Anderson CJ. Adults with pediatric-onset spinal cord injuries: part 3: impact of medical complications. J Spinal Cord Med. 2002;25(4):297–305. [DOI] [PubMed] [Google Scholar]
- 3.Schottler J, Vogel L, Chafetz R, Mulcahey MJ. Patient and caregiver knowledge of autonomic dysreflexia among youth with spinal cord injury.Spinal Cord. 2009;47(9):681–6. [DOI] [PubMed] [Google Scholar]
- 4.Vogel L, Anderson C. Outcomes of adults with pediatric onset spinal cord injury. Top Spinal Cord Inj Rehabil. 2005;10(4):109–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fehlings MG, Tetreault LA, Wilson JR, Kwon BK, Burns AS, Martin AR, et al. A Clinical Practice Guideline for the Management of Acute Spinal Cord Injury: Introduction, Rationale, and Scope. Global Spine J. 2017;7(3 Suppl):84S–94S. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Alhuthaifi F, Krzak J, Hanke T, Vogel LC. Predictors of functional outcomes in adults with traumatic spinal cord injury following inpatient rehabilitation: A systematic review. J Spinal Cord Med. 2017;40(3):282–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Löfvenmark I, Norrbrink C, Nilsson-Wikmar L, Hultling C, Chakandinakira S, Hasselberg M. Traumatic spinal cord injury in Botswana: characteristics, aetiology and mortality. Spinal Cord. 2015;53(2):150–4. [DOI] [PubMed] [Google Scholar]
- 8.Pickett GE, Campos-Benitez M, Keller JL, Duggal N. Epidemiology of traumatic spinal cord injury in Canada. Spine (Phila Pa 1976). 2006;31(7):799–805. [DOI] [PubMed] [Google Scholar]
- 9.Stein DM, Knight WA., 4th. Emergency Neurological Life Support: Traumatic Spine Injury. Neurocrit Care. 2017;27(Suppl 1):170–80. [DOI] [PubMed] [Google Scholar]
- 10.New PW, Baxter D, Farry A, Noonan VK. Estimating the incidence and prevalence of traumatic spinal cord injury in Australia. Arch Phys Med Rehabil. 2015;96(1):76–83. [DOI] [PubMed] [Google Scholar]
- 11.Knútsdóttir S, Thorisdottir H, Sigvaldason K, Jonsson H, Jr, Björnsson A, Ingvarsson P. Epidemiology of traumatic spinal cord injuries in Iceland from 1975 to 2009. Spinal cord. 2012;50(2):123–6. [DOI] [PubMed] [Google Scholar]
- 12.Rahimi-Movaghar V, Saadat S, Rasouli MR, Ganji S, Ghahramani M, Zarei MR, et al. Prevalence of spinal cord injury in Tehran, Iran. J Spinal Cord Med. 2009;32(4):428–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cirak B, Ziegfeld S, Knight VM, Chang D, Avellino AM, Paidas CN. Spinal injuries in children. J Pediatr Surg. 2004;39(4):607–12. [DOI] [PubMed] [Google Scholar]
- 14.Reynolds R. Pediatric spinal injury. Curr Opin Pediatr. 2000;12(1):67–71. [DOI] [PubMed] [Google Scholar]
- 15.Parisini P, Di Silvestre M, Greggi T. Treatment of spinal fractures in children and adolescents: long-term results in 44 patients. Spine (Phila Pa 1976). 2002;27(18):1989–94. [DOI] [PubMed] [Google Scholar]
- 16.Hamilton MG, Myles ST. Pediatric spinal injury: review of 174 hospital admissions. J Neurosurg. 1992;77(5):700–4. [DOI] [PubMed] [Google Scholar]
- 17.Clark P, Letts M. Trauma to the thoracic and lumbar spine in the adolescent. Can J Surg. 2001;44(5):337–45. [PMC free article] [PubMed] [Google Scholar]
- 18.Eubanks JD, Gilmore A, Bess S, Cooperman DR. Clearing the pediatric cervical spine following injury. J Am Acad Orthop Surg. 2006;14(9):552–64. [DOI] [PubMed] [Google Scholar]
- 19.Garg H, Pahys J, Cahill PJ. Thoracic and Lumbar Spine Injuries. InPediatric Orthopedic Surgical Emergencies 2012 (pp. 67–86). Springer, New York, NY. [Google Scholar]
- 20.Hall DE, Boydston W. Pediatric neck injuries. Pediatr Rev. 1999;20(1):13–9. [DOI] [PubMed] [Google Scholar]
- 21.Pang D, Sun PP. Pediatric vertebral column and spinal cord injuries. Neurological Surgery. Philadelphia, WB Saunders. 2004:3315–57. [Google Scholar]
- 22.Kewalramani LS, Tori JA. Spinal cord trauma in children. Neurologic patterns, radiologic features, and pathomechanics of injury. Spine (Phila Pa 1976). 1980;5(1):11–8. [PubMed] [Google Scholar]
- 23.Osenbach RK, Menezes AH. Pediatric spinal cord and vertebral column injury. Neurosurgery. 1992;30(3):385–90. [DOI] [PubMed] [Google Scholar]
- 24.Nitecki S, Moir CR. Predictive factors of the outcome of traumatic cervical spine fracture in children. J Pediatr Surg. 1994;29(11):1409–11. [DOI] [PubMed] [Google Scholar]
- 25.Gouti M, Metzis V, Briscoe J. The route to spinal cord cell types: a tale of signals and switches. Trends Genet. 2015;31(6):282–9. [DOI] [PubMed] [Google Scholar]
- 26.Ogden JA. Skeletal Injury in the Child Spine. 1990. [Google Scholar]
- 27.Fesmire FM, Luten RC. The pediatric cervical spine: developmental anatomy and clinical aspects. J Emerg Med. 1989;7(2):133–42. [DOI] [PubMed] [Google Scholar]
- 28.Herman MJ, Pizzutillo PD. Cervical spine disorders in children. Orthop Clin North Am. 1999;30(3):457–66. [DOI] [PubMed] [Google Scholar]
- 29.Harris JH, Mirvis SE. The radiology of acute cervical spine trauma. Lippincott Williams & Wilkins; 1996. [Google Scholar]
- 30.Swischuk LE. Emergency imaging of the acutely ill or injured child. Lippincott Williams & Wilkins; 2000. [Google Scholar]
- 31.Ogden JA. Radiology of postnatal skeletal development. Skeletal Radiol. 1984;12(3):169–77. [DOI] [PubMed] [Google Scholar]
- 32.Peterson HA. Spine (Vertebral Physeal Endplate). Epiphyseal Growth Plate Fractures. 2007:797–805. [Google Scholar]
- 33.Dwek JR, Chung CB. Radiography of Cervical Spine Injury in Children: Are Flexion—Extension Radiographs Useful for Acute Trauma? Am J Roentgenol. 2000;174(6):1617–9. [DOI] [PubMed] [Google Scholar]
- 34.Rathore M, Sharma DK, Sinha MB, Siddiqui AU, Trivedi S. A focused review–Thoracolumbar spine: Anatomy, biomechanics and clinical significance. Indian J Clin Anat Physiol. 2014;1(1):41–7. [Google Scholar]
- 35.Anderson DK, Means ED, Waters TR, Green ES. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg. 1982;56(1):106–13. [DOI] [PubMed] [Google Scholar]
- 36.Tubbs RS, Blouir MC, Romeo AK, Mortazavi MM, Cohen-Gadol AA. Spinal cord ischemia and atherosclerosis: a review of the literature. Br J Neurosurg. 2011;25(6):666–70. [DOI] [PubMed] [Google Scholar]
- 37.Sekhon LHS, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 2001:26(24S):S2–12. [DOI] [PubMed] [Google Scholar]
- 38.Kobayashi T. Experimental study on pathological phases of whiplash injury. Nihon Seikeigeka Gakkai Zasshi. 1968;42(1):1–12. [PubMed] [Google Scholar]
- 39.Rossignol S, Schwab M, Schwartz M, Fehlings MG. Spinal cord injury: time to move? J Neurosci. 2007;27(44):11782–92 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mortazavi MM, Verma K, Deep A, Esfahani FB, Pritchard PR, Tubbs RS, et al. Chemical priming for spinal cord injury: a review of the literature part II—potential therapeutics. Childs Nerv Syst. 2011;27(8):1307–16. [DOI] [PubMed] [Google Scholar]
- 41.Sun PP, Poffenbarger GJ, Durham S, Zimmerman RA. Spectrum of occipitoatlantoaxial injury in young children. J Neurosurg Spine. 2000;93(1):28–39. [DOI] [PubMed] [Google Scholar]
- 42.Marshall KW, Koch BL, Egelhoff JC. Air bag-related deaths and serious injuries in children: injury patterns and imaging findings. Am J Neuroradiol. 1998;19(9):1599–607. [PMC free article] [PubMed] [Google Scholar]
- 43.Dickman CA, Papadopoulos SM, Sonntag VK, Spetzler RF, Rekate HL, Drabier J. Traumatic occipitoatlantal dislocations. J Spinal Disord. 1993;6(4):300–13. [DOI] [PubMed] [Google Scholar]
- 44.Mortazavi M, Gore PA, Chang S, Tubbs RS, Theodore N. Pediatric cervical spine injuries: a comprehensive review. Childs Nerv Syst. 2011;27(5):705–17. [DOI] [PubMed] [Google Scholar]
- 45.Connolly B, Emery D, Armstrong D. The odontoid synchondrotic slip: an injury unique to young children. Pediatr Radiol. 1995;25(Suppl 1):S129–33. [PubMed] [Google Scholar]
- 46.Leonard JC. Cervical spine injury. Pediatr Clin North Am. 2013;60(5):1123–37. [DOI] [PubMed] [Google Scholar]
- 47.Horn EM, Lekovic GP, Feiz-Erfan I, Sonntag VK, Theodore N. Cervical magnetic resonance imaging abnormalities not predictive of cervical spine instability in traumatically injured patients: invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine. 2004;1(1):39–42. [DOI] [PubMed] [Google Scholar]
- 48.Fielding JW, Hawkins RJ. Atlanto-axial rotatory fixation.(Fixed rotatory subluxation of the atlanto-axial joint). J Bone Joint Surg Am. 1977;59(1):37–44. [PubMed] [Google Scholar]
- 49.Pang D, Li V. Atlantoaxial rotatory fixation: part 3—a prospective study of the clinical manifestation, diagnosis, management, and outcome of children with alantoaxial rotatory fixation. Neurosurgery. 2005;57(5):954–72. [DOI] [PubMed] [Google Scholar]
- 50.Torg JS, Corcoran TA, Thibault LE, Pavlov H, Sennett BJ, Naranja RJ, et al. Cervical cord neurapraxia: classification, pathomechanics, morbidity, and management guidelines. J Neurosurg. 1997;87(6):843–50. [DOI] [PubMed] [Google Scholar]
- 51.Torg JS, Pavlov HE, Genuario SE, Sennett B, Wisneski RJ, Robie BH, et al. Neurapraxia of the cervical spinal cord with transient quadriplegia. J Bone Joint Surg Am. 1986;68(9):1354–70. [PubMed] [Google Scholar]
- 52.Tat ST, Mejia MJ, Freishtat RJ. Imaging, clearance, and controversies in pediatric cervical spine trauma. Pediatr Emerg Care. 2014;30(12):911–5. [DOI] [PubMed] [Google Scholar]
- 53.Pollack CV, Jr, Hendey GW, Martin DR, Hoffman JR, Mower WR, NEXUS Group. Use of flexion-extension radiographs of the cervical spine in blunt trauma. Ann Emerg Med. 2001;38(1):8–11. [DOI] [PubMed] [Google Scholar]
- 54.Easter JS, Barkin R, Rosen CL, Ban K. Cervical spine injuries in children, part I: mechanism of injury, clinical presentation, and imaging. J Emerg Med. 2011;41(2):142–50. [DOI] [PubMed] [Google Scholar]
- 55.Hale AT, Alvarado A, Bey AK, Pruthi S, Mencio GA, Bonfield CM, et al. X-ray vs. CT in identifying significant C-spine injuries in the pediatric population. Childs Nerv Syst. 2017;33(11):1977–83. [DOI] [PubMed] [Google Scholar]
- 56.Schenarts PJ, Diaz J, Kaiser C, Carrillo Y, Eddy V, Morris JA., Jr. Prospective comparison of admission computed tomographic scan and plain films of the upper cervical spine in trauma patients with altered mental status. J Trauma. 2001;51(4):663–9. [DOI] [PubMed] [Google Scholar]
- 57.Flynn JM, Closkey RF, Mahboubi S, Dormans JP. Role of magnetic resonance imaging in the assessment of pediatric cervical spine injuries. J Pediatr Orthop. 2002;22(5):573–7. [PubMed] [Google Scholar]
- 58.Kaiser ML, Whealon MD, Barrios C, Kong AP, Lekawa ME, Dolich MO. The current role of magnetic resonance imaging for diagnosing cervical spine injury in blunt trauma patients with negative computed tomography scan. Am Surg. 2012;78(10):1156–60. [DOI] [PubMed] [Google Scholar]
- 59.Ngatchou W, Beirnaert J, Lemogoum D, Bouland C, Youatou P, Ramadan AS, et al. Application of the Canadian C-Spine rule and nexus low criteria and results of cervical spine radiography in emergency condition. Pan Afr Med J. 2018;30:157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Fockens MM, Wang J, Maas M, Wilson DJ, Goslings JC, Schep NW, et al. Triage tools for detecting cervical spine injury in pediatric trauma patients. Cochrane Database Syst Rev. 2017;12:CD011686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Pang D, Wilberger JE. Spinal cord injury without radiographic abnormalities in children. J Neurosurg. 1982;57(1):114–29. [DOI] [PubMed] [Google Scholar]
- 62.Dreizin D, Kim W, Kim JS, Boscak AR, Bodanapally UK, Munera F, et al. Will the real SCIWORA please stand up? Exploring clinicoradiologic mismatch in closed spinal cord injuries. Am J Roentgenol. 2015;205(4):853–60. [DOI] [PubMed] [Google Scholar]
- 63.Panagopoulos D. A Case of SCIWORA with Uncommon Combination of Neurological and Imaging Findings. EC Paediatr.2018;6:498–506. [Google Scholar]
- 64.Boese CK, Nerlich M, Klein SM, Wirries A, Ruchholtz S, Lechler P. Early magnetic resonance imaging in spinal cord injury without radiological abnormality in adults: a retrospective study. J Trauma Acute Care Surg. 2013;74(3):845–8. [DOI] [PubMed] [Google Scholar]
- 65.Trigylidas T, Yuh SJ, Vassilyadi M, Matzinger MA, Mikrogianakis A. Spinal cord injuries without radiographic abnormality at two pediatric trauma centers in Ontario. Pediatr Neurosurg. 2010;46(4):283–9. [DOI] [PubMed] [Google Scholar]
- 66.Mahajan P, Jaffe DM, Olsen CS, Leonard JR, Nigrovic LE, Rogers AJ, et al. Spinal cord injury without radiologic abnormality in children imaged with magnetic resonance imaging. J Trauma Acute Care Surg. 2013;75(5):843–7. [DOI] [PubMed] [Google Scholar]
- 67.Boese CK, Oppermann J, Siewe J, Eysel P, Scheyerer MJ, Lechler P. Spinal cord injury without radiologic abnormality in children: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2015;78(4):874–82. [DOI] [PubMed] [Google Scholar]
- 68.Shank CD, Walters BC, Hadley MN. Management of acute traumatic spinal cord injuries. In Handbook of clinical neurology 2017. January 1 (Vol. 140, pp. 275–298). Elsevier. [DOI] [PubMed] [Google Scholar]
- 69.Seid T, Ramaiah R, Grabinsky A. Pre–hospital care of pediatric patients with trauma. Int J Crit Illn Inj Sci. 2012;2(3):114–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Huerta C, Griffith R, Joyce SM. Cervical spine stabilization in pediatric patients: evaluation of current techniques. Ann Emerg Med. 1987;16(10):1121–6. [DOI] [PubMed] [Google Scholar]
- 71.Kliegman R., Nelson W. Nelson textbook of pediatrics. 2016. [Google Scholar]
- 72.Morparia K, Berg J, Basu S. Confidence level of pediatric trainees in management of shock states. World J Crit care Med. 2018;7:31–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Hadley MN, Walters BC, Aarabi B, Dhall SS, Gelb DE, Hurlbert RJ, et al. Clinical assessment following acute cervical spinal cord injury. Neurosurgery. 2013;72(suppl_3):40–53. [DOI] [PubMed] [Google Scholar]
- 74.Kirshblum SC, Burns SP, Biering-Sorensen F, Donovan W, Graves DE, Jha A, et al. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med. 2011;34(6):535–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Burns AS, Lee BS, Ditunno JF, Tessler A. Patient Selection for Clinical Trials: The Reliability of the Early Spinal Cord Injury Examination. J Neurotrauma. 2003;20(5):477–82. [DOI] [PubMed] [Google Scholar]
- 76.DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehabil. 1993;74(3):248–54. [PubMed] [Google Scholar]
- 77.Chng YM, Sagarin M, Chiang V, Walls R. Pediatric emergency airway management. Acad Emerg Med. 2004;11(5):438–9. [Google Scholar]
- 78.Li J, Murphy-Lavoie H, Bugas C, Martinez J, Preston C. Complications of emergency intubation with and without paralysis. Am J Emerg Med. 1999;17(2):141–3. [DOI] [PubMed] [Google Scholar]
- 79.Yamamoto LG. Emergency airway management–rapid sequence intubation. Textbook of Pediatric Emergency Medicine. Philadelphia: Wolters Kluwer; 2010:74–84. [Google Scholar]
- 80.Gerardi MJ, Sacchetti AD, Cantor RM, Santamaria JP, Gausche M, Lucid W, et al. Rapid-sequence intubation of the pediatric patient. Ann Emerg Med. 1996;28(1):55–74. [DOI] [PubMed] [Google Scholar]
- 81.Mathias CJ. Orthostatic hypotension and paroxysmal hypertension in humans with high spinal cord injury. Prog Brain Res. 2006;152:231–43. [DOI] [PubMed] [Google Scholar]
- 82.Claydon VE, Steeves JD, Krassioukov A. Orthostatic hypotension following spinal cord injury: Understanding clinical pathophysiology. Spinal Cord. 2006;44(6):341–51. [DOI] [PubMed] [Google Scholar]
- 83.Mathias CJ, Christensen NJ, Frankel HL, Peart WS. Renin Release during Head-up Tilt Occurs Independently of Sympathetic Nervous Activity in Tetraplegic Man. Clin Sci. 1980;59(4):251–6. [DOI] [PubMed] [Google Scholar]
- 84.Teasell RW, Arnold JMO, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000;81(4):506–16. [DOI] [PubMed] [Google Scholar]
- 85.Thompson AJ, McSwain SD, Webb SA, Stroud MA, Streck CJ. Venous thromboembolism prophylaxis in the pediatric trauma population. J Pediatr Surg. 2013;48(6):1413–21. [DOI] [PubMed] [Google Scholar]
- 86.Satkunendrarajah K, Nassiri F, Karadimas SK, Lip A, Yao G, Fehlings MG. Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection. Exp Neurol. 2016;276:59–71. [DOI] [PubMed] [Google Scholar]
- 87.Bagriyanik HA, Ozogul C, Alaygut E, Gokmen N, Kucukguclu S, Gunerli A, et al. Neuroprotective effects of ketorolac tromethamine after spinal cord injury in rats: an ultrastructural study. Adv Ther. 2008;25(2):152–8. [DOI] [PubMed] [Google Scholar]
- 88.Norimatsu Y, Ohmori T, Kimura A, Madoiwa S, Mimuro J, Seichi A, et al. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am J Pathol. 2012;180(4):1625–35. [DOI] [PubMed] [Google Scholar]
- 89.Süzer T, Coskun E, Islekel H, Tahta K. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord. 1999;37(7):480–4. [DOI] [PubMed] [Google Scholar]
- 90.Kaptanoglu E, Beskonakli E, Solaroglu I, Kilinc A, Taskin Y. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev. 2003;26(4):283–7. [DOI] [PubMed] [Google Scholar]
- 91.Lee JM, Yan P, Xiao Q, Chen S, Lee KY, Hsu CY, et al. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury. J Neurosci. 2008;28(12):3141–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Gaviria M, Privat A, d’Arbigny P, Kamenka JM, Haton H, Ohanna F. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res. 2000;874(2):200–9. [DOI] [PubMed] [Google Scholar]
- 93.Feldblum S, arnaud S, simon M, rabin O, d’Arbigny PI. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury. J Neurotrauma. 2000;17(11):1079–93. [DOI] [PubMed] [Google Scholar]
- 94.Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury—a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991;324(26):1829–38. [DOI] [PubMed] [Google Scholar]
- 95.Bracken MB. Summary statement: The Sygen®(GM-1 Ganglioside) clinical trial in acute spinal cord injury. Spine. 2001;26(24S):S99–100. [DOI] [PubMed] [Google Scholar]
- 96.Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517–21. [DOI] [PubMed] [Google Scholar]
- 97.Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg. 1987;66(2):181–5. [DOI] [PubMed] [Google Scholar]
- 98.Torres BB, Caldeira FM, Gomes MG, Serakides R, de Marco Viott A, Bertagnolli AC, et al. Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats. Int J Exp Pathol. 2010;91(6):530–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Aslan A, Cemek M, Buyukokuroglu ME, Altunbas K, Bas O, Yurumez Y, et al. Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J. 2009;18(10):1442–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Han ZA, Song DH, Oh HM, Chung ME. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Ann Neurol. 2016;79(4):569–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. Neurology. 1994. November;44(11 Suppl 9):S44–51. [PubMed] [Google Scholar]
- 102.Brown GL, Duffell LD, Mirbagheri MM. Classifying and predicting endurance outcomes of α 2-adrenergic agonist intervention in spinal cord injury. Conf Proc IEEE Eng Med Biol Soc. 2014;2014>:5896–9. [DOI] [PubMed] [Google Scholar]
- 103.Behrman AL, Ardolino EM, Harkema SJ. Activity-based therapy: from basic science to clinical application for recovery after spinal cord injury. J Neurol Phys Ther. 2017;41(Suppl 3 IV STEP Spec Iss): S39–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Teeter L, Gassaway J, Taylor S, LaBarbera J, McDowell S, Backus D, et al. Relationship of physical therapy inpatient rehabilitation interventions and patient characteristics to outcomes following spinal cord injury: the SCIRehab project. J Spinal Cord Med. 2012;35(6):503–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Edgerton VR, Tillakaratne NJ, Bigbee AJ, de Leon RD, Roy RR. Plasticity of the spinal neural circuitry after injury. Annu Rev Neurosci. 2004;27:145–67. [DOI] [PubMed] [Google Scholar]
- 106.Harkema SJ, Schmidt-Read M, Behrman AL, Bratta A, Sisto SA, Edgerton VR. Establishing the NeuroRecovery Network: multisite rehabilitation centers that provide activity-based therapies and assessments for neurologic disorders. Arch Phys Med Rehabil. 2012;93(9):1498–507. [DOI] [PubMed] [Google Scholar]
- 107.Calhoun CL, Schottler J, Vogel LC. Recommendations for mobility in children with spinal cord injury. Top Spinal Cord Inj Rehabil. 2013;19(2):142–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Roy RR, Harkema SJ, Edgerton VR. Basic concepts of activity-based interventions for improved recovery of motor function after spinal cord injury. Arch Phys Med Rehabil. 2012;93(9):1487–97. [DOI] [PubMed] [Google Scholar]
- 109.Ota T, Akaboshi K, Nagata M, Sonoda S, Domen K, Seki M, et al. Functional assessment of patients with spinal cord injury: measured by the motor score and the Functional Independence Measure. Spinal Cord. 1996;34(9):531–5. [DOI] [PubMed] [Google Scholar]
- 110.Xiong T, Hartley S. Challenges in linking health-status outcome measures and clinical assessment tools to the ICF. Adv Physiother. 2008;10(3):152–6. [Google Scholar]
- 111.Ardolino EM, Mulcahey MJ, Trimble S, Argetsinger L, Bienkowski M, Mullen C, et al. Development and initial validation of the pediatric Neuromuscular Recovery Scale. Pediatr Phys Ther. 2016;28(4):416–26. [DOI] [PubMed] [Google Scholar]
- 112.Özkan N, Wrede K, Ardeshiri A, Sariaslan Z, Stein KP, Dammann P, et al. Management of traumatic spinal injuries in children and young adults. Childs Nerv Syst. 2015;31(7):1139–48. [DOI] [PubMed] [Google Scholar]
- 113.Birney TJ, Hanley ENJ. Traumatic cervical spine injuries in childhood and adolescence. Spine (Phila Pa 1976). 1989;14(12):1277–82. [DOI] [PubMed] [Google Scholar]
- 114.Sherk HH, Schut L, Lane JM. Fractures and dislocations of the cervical spine in children. Orthop Clin North Am. 1976;7(3):593–604. [PubMed] [Google Scholar]
- 115.Eleraky MA, Theodore N, Adams M, Rekate HL, Sonntag VK. Pediatric cervical spine injuries: report of 102 cases and review of the literature. J Neurosurg. 2000;92(1):12–7. [DOI] [PubMed] [Google Scholar]
- 116.Duhem R, Tonnelle V, Vinchon M, Assaker R, Dhellemmes P. Unstable upper pediatric cervical spine injuries: report of 28 cases and review of the literature. Childs Nerv Syst. 2008;24(3):343–8. [DOI] [PubMed] [Google Scholar]
- 117.Stulík J, Nesnídal P, Kryl J, Vyskočil T, Barna M. Unstable injuries to the upper cervical spine in children and adolescents. Acta Chir Orthop Traumatol Cech. 2013;80(2):106–13. [PubMed] [Google Scholar]
- 118.Cofano F, Boido M, Monticelli M, Zenga F, Ducati A, Vercelli A, Garbossa D. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20(11):E2698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):E1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Boido M, Piras A, Valsecchi V, Spigolon G, Mareschi K, Ferrero I, et al. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy. 2014;16(8):1059–72. [DOI] [PubMed] [Google Scholar]
- 121.Yuan X, Logan TM, Ma T. Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy? Front Immunol; 2019;10:977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Jeon SR, Park JH, Lee JH, Kim DY, Kim HS, Sung IY, et al. Treatment of spinal cord injury with bone marrow-derived, cultured autologous mesenchymal stem cells. Tissue Eng Regen Med. 2010;7(3):316–22. [Google Scholar]
- 123.El-Kheir WA, Gabr H, Awad MR, Ghannam O, Barakat Y, Farghali HA, et al. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. Cell Transplant. 2014;23(6):729–45. [DOI] [PubMed] [Google Scholar]
- 124.Chua SJ, Bielecki R, Yamanaka N, Fehlings MG, Rogers IM, Casper RF. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine. 2010;35(16):1520–6. [DOI] [PubMed] [Google Scholar]
- 125.Caron I, Rossi F, Papa S, Aloe R, Sculco M, Mauri E, et al. A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. Biomaterials. 2016;75:135–47. [DOI] [PubMed] [Google Scholar]
- 126.Bottai D, Scesa G, Cigognini D, Adami R, Nicora E, Abrignani S, et al. Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury. Exp Neurol. 2014;254>:121–33. [DOI] [PubMed] [Google Scholar]
- 127.Gao S, Ding J, Xiao HJ, Li ZQ, Chen Y, Zhou XS, Wang JE, Wu J, Shi WZ. Anti-inflammatory and anti-apoptotic effect of combined treatment with methylprednisolone and amniotic membrane mesenchymal stem cells after spinal cord injury in rats. Neurochem Res. 2014;39(8):1544–52. [DOI] [PubMed] [Google Scholar]
- 128.Menezes K, Nascimento MA, Gonçalves JP, Cruz AS, Lopes DV, Curzio B, et al. Human mesenchymal cells from adipose tissue deposit laminin and promote regeneration of injured spinal cord in rats. PloS one. 2014;9(5):e96020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Jin MC, Medress ZA, Azad TD, Doulames VM, Veeravagu A. Stem cell therapies for acute spinal cord injury in humans: a review. Neurosurg Focus. 2019;46(3):E10. [DOI] [PubMed] [Google Scholar]
- 130.Ahuja CS, Fehlings M. Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury. Stem Cells Transl Med. 2016;5(7):914–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A, Watanabe K, Ishii K, Kato F, Fujita H, Takahashi T. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci. 2005;22(12):3036–46. [DOI] [PubMed] [Google Scholar]
- 132.Carter LM, McMahon SB, Bradbury EJ. Delayed treatment with chondroitinase ABC reverses chronic atrophy of rubrospinal neurons following spinal cord injury. Exp Neurol. 2011;228:149–56. [DOI] [PubMed] [Google Scholar]
- 133.Bartus K, James ND, Didangelos A, Bosch KD, Verhaagen J, Yáñez-Muñoz RJ, et al. Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury. J Neurosci. 2014;34(14):4822–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Freund P, Schmidlin E, Wannier T, Bloch J, Mir A, Schwab ME, et al. Nogo-A–specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med. 2006;12(7):790–2. [DOI] [PubMed] [Google Scholar]
- 135.Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K, Mir A, Rausch M, Kindler D, Hamers FP. Nogo-A antibody improves regeneration and locomotion of spinal cord–injured rats. Ann Neurol. 2005;58(5):706–19. [DOI] [PubMed] [Google Scholar]
- 136.Meininger V, Pradat PF, Corse A, Al-Sarraj S, Brooks BR, Caress JB, et al. Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial. PLoS One. 2014;9(5):e97803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Meininger V, Genge A, van den Berg LH, Robberecht W, Ludolph A, Chio A, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(3):208–16. [DOI] [PubMed] [Google Scholar]
- 138.Tsai EC, Dalton PD, Shoichet MS, Tator CH. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials. 2006;27(3):519–33. [DOI] [PubMed] [Google Scholar]
- 139.Stokols S, Tuszynski MH. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials. 2006;27(3):443–51. [DOI] [PubMed] [Google Scholar]
- 140.Taylor SJ, McDonald JW, 3rd, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release. 2004;98(2):281–94. [DOI] [PubMed] [Google Scholar]
- 141.Johnson PJ, Parker SR, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng. 2009;104(6):1207–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Mothe AJ, Tam RY, Zahir T, Tator CH, Shoichet MS. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials. 2013;34(15):3775–83. [DOI] [PubMed] [Google Scholar]
- 143.Shen YH, Shoichet MS, Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater. 2008;4(3):477–89. [DOI] [PubMed] [Google Scholar]
- 144.Leipzig ND, Xu C, Zahir T, Shoichet MS. Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A. 2010;93(2):625–33. [DOI] [PubMed] [Google Scholar]
- 145.Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials. 2006;27(11):2370–9. [DOI] [PubMed] [Google Scholar]